News Archives - Page 730 of 768

MondayAug 06, 2018 1:51 pm

Zenosense, Inc. (ZENO) Aims to Revolutionize Cardiac Diagnostics Market

Handheld technology platform in development to deliver high sensitivity, laboratory accuracy testing for cardiac biomarkers at the point of care Cardiac biomarker testing market expected to reach $7.2 billion this year Major potential for the patented technology to be applied to the detection of numerous other conditions, including cancer, HIV, hepatitis, autoimmune diseases and many others With cardiovascular disease being the leading cause of death globally for both men and women, and one in four Americans dying of heart disease every year (http://ibn.fm/GD0Ea), the need for more accurate and faster cardiac diagnostic methods is more than evident. Health care technology company…

MondayAug 06, 2018 1:35 pm

Auscrete Corp. (ASCK) to Setup Ontario Production Plant with Canadian Investment Group

Auscrete owns proprietary technology in hybrid insulated lightweight concrete building products manufacturing Company’s focus is on the “Green” movement Auscrete is finalizing plans to establish a 75 percent company-owned production plant in Ontario, Canada, with a Canadian Investment Group A building materials manufacturing company based in Washington, Auscrete Corp. (OTC: ASCK) is at the vanguard of the “Green” movement. The company’s mission is to make affordable, technology-driven and eco-friendly housing available to those who were never before given the opportunity to realize the American Dream. Auscrete Canada Ltd., as the new company is known, was formed to finance the construction…

MondayAug 06, 2018 1:16 pm

CytoDyn Inc. (CYDY) Reports HIV Single Agent Therapy Progress Following Improved Response Rate at Higher Dose

PRO 140 single agent therapy is the first successful single agent therapy in the history of HIV for a sub-population of HIV Response rate for the company’s innovative PRO 140 nearly doubled after dosage increase About 70 percent of phase 3 trial participants treated with higher doses have achieved viral load suppression The monotherapy would allow patients to self-administer one dose per week of PRO 140 at home Biotechnology company CytoDyn Inc. (OTCQB: CYDY) has announced significant developmental progress for its PRO 140 monotherapy for human immunodeficiency virus (HIV) after noticing improved response rates at higher doses of the treatment…

MondayAug 06, 2018 12:26 pm

Virtual Crypto Technologies Inc. (VRCP) Enthused by Signs of Changing SEC Sentiment toward Bitcoin ETFs

U.S. Securities and Exchange Commission continues to review cryptocurrency ETF applications Application by Chicago Board Options Exchange generating buzz among investors VRCP’s ATM platform helping to strengthen bitcoin’s legitimacy through “spendability” and technological practicality As the U.S. Securities and Exchange Commission weighs several applications seeking to establish an exchange-traded investment fund (ETF) for the bitcoin cryptocurrency, Virtual Crypto Technologies Inc. (OTCQB: VRCP) is applauding the signs that regulatory sentiment in the United States appears to be shifting in favor of cryptocurrencies, paving the way for anticipated mass adoption of bitcoin (Crypto: BTC) and other cryptocurrencies. Virtual Crypto Technologies is a…

FridayAug 03, 2018 2:42 pm

Earth Science Tech, Inc. (ETST) Poised to Leverage Full-Spectrum CBD Product Line in Projected $2 Billion Market

Earth Science Tech to add three full-spectrum CBD chocolate offerings to product line Testing to begin on CBD-based patent products Earth Science Tech products will be available to 90,000 retail outlets throughout U.S. On the heels of a major decision by the U.S. Food and Drug Administration (FDA) to approve Epidiolex, a drug derived from pure cannabidiol (CBD), to treat seizures associated with certain forms of severe epilepsy, Earth Science Tech, Inc. (OTC: ETST) is repositioning its line of full-spectrum CBD offerings. Included in this move is the announcement that the company, along with joint venture partner Karmavore Superfoods, will…

FridayAug 03, 2018 1:55 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enabling Companies to Produce High-Quality Cannabis-Infused Products

80 percent of the company’s total revenue anticipated from the licensing of DehydraTECH™ Nuke Enterprises renewed its license, sending a strong vote of confidence in the technology Enabled GP Holdings to create a high-performing cannabis-infused beverage Biolog Inc. is developing products which will allow processors and consumers to turn almost any food or beverage into a cannabis edible Beginning production of a line of cannabis-infused alcohol-free beverages through a new licensing agreement Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a drug delivery platform innovator, utilizes its unique patented DehydraTECH™ delivery technology to enhance the products of its clients. This patented…

FridayAug 03, 2018 1:22 pm

ChineseInvestors.com, Inc. (CIIX) CEO Remains Bullish on Bitcoin Pricing Due to Supply and Demand

Warren Wang, CEO of CIIX, says in MoneyTV interview that he believes CIIX will enjoy ‘good times’ in 2019 and 2020 as its program initiatives perform well He remains bullish on bitcoin pricing due to the fixed supply of 21 million coins and the potential demand from the far larger 1.4 billion-person population of China CIIX offers a suite of cryptocurrency services, including education, mining for coins and media; it offers its Chinese-speaking audience podcasts and a daily broadcast from the NYSE ChineseInvestors.com, Inc. (OTCQB: CIIX) CEO Warren Wang recently predicted that CIIX would perform well and provide ‘good times’…

FridayAug 03, 2018 12:56 pm

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Initiates Planning of MMI Geochemical Survey at Irgon Lithium Mine Project

Demand for lithium batteries in electric vehicles, energy storage devices and portable electronics continues to fuel lithium market forecasts QMC working with SGS Canada, Inc. to search out buried minerals through mobile metal ion (“MMI”) geochemical survey Company confident that additional exploration will expand property resource, historically reported to be in excess of 1.2 million tons grading at 1.5 percent Li2O As investment research agencies continue to predict a boom market for lithium suppliers, QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) is moving forward with its plans to explore and develop a historical spodumene-bearing pegmatite resource located…

FridayAug 03, 2018 11:50 am

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Advances Controlled Synthesis of Scorpion Venom Peptides for Brain Therapies

PreveCeutical’s ‘Nature Identical™’ efforts aim to create consistently reproducible versions of found-in-nature therapeutics Company has begun engineering redesign phase of select identified peptides derived from famed scorpion venom Preventative therapeutics market expected to generate $196.9 billion in revenues by 2024, demonstrating alternative health products’ potential PreveCeutical Medical Inc.’s (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) efforts to develop a synthesized and consistently reproducible ‘Nature Identical™’ scorpion venom, popular as a pain reliever and cancer therapy, has taken a new step toward marketability as the company commences work on re-engineering venom peptide components to stabilize them. The biotech company based in British…

ThursdayAug 02, 2018 2:13 pm

Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Subsidiary Inks Another Supply Contract for Upcoming Cannabis Crop

Operating in world’s two largest cannabis markets – California and Canada Cannabis concentrate extraction service agreement inked with Cannabis Strategic Venture subsidiary Pure Applied Sciences, Inc. to provide white label services of high quality, ultra-purified cannabis extracts Construction underway in California and Canada of large scale, purpose-built current cGMP designed greenhouses for cannabis cultivation and production Supply agreement with Canopy Growth Corporation to provide up to 90,000 kg of cannabis over two years beginning in early 2019 Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF), a vertically integrated medical cannabis company headquartered in Vancouver, Canada, is committed to delivering safe, consistent, high-quality products and…

Site Search

Company Search

Category: News